SCHEMBL25524602

SCHEMBL25524602

CCC(C)c1cccc(N2CCCCC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.49
HDAC4 P56524 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
GFER P55789 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
AGXT P21549 1/20 0.43
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
RECQL P46063 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KCNQ2 O43526 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23709488 0.86 ADRA2C (0.54) ALDH1A1KDM4EGFERL3MBTL1AGXT
SCHEMBL4547919 0.83 NOTUM (0.52) PRMT6ALDH1A1KDM4EL3MBTL1AGXT
SCHEMBL27408091 0.82 CYP3A4 (0.38) HDAC4HDAC2HDAC8ALDH1A1LMNA
SCHEMBL3534359 0.81 NOTUM (0.54) PRMT6ALDH1A1KDM4EGFERL3MBTL1
SCHEMBL24136303 0.80 ALDH1A1 (0.50) ALDH1A1KDM4EGFERL3MBTL1LMNA
SCHEMBL9839870 0.79 PRMT6 (0.44) PRMT6ALDH1A1KDM4EGFERL3MBTL1
SCHEMBL5791930 0.78 PRMT6 (0.47) PRMT6ALDH1A1KDM4EGFERL3MBTL1
SCHEMBL24781211 0.78 HDAC4 (0.39) HDAC4HDAC2HDAC8ALDH1A1KDM4E
SCHEMBL19710909 0.78 RORC (0.43) HDAC4HDAC2HDAC8ALDH1A1KDM4E
SCHEMBL14703927 0.78 ALDH1A1 (0.51) ALDH1A1KDM4EGFERL3MBTL1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150946-A1 HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS OXFORD FINANCE LLC 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150946-A1 HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS STAT5A, STAT5B, STAT3 PRMT6 1211/4885HDAC4 212/4885HDAC2 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.